JP2009514794A5 - - Google Patents

Download PDF

Info

Publication number
JP2009514794A5
JP2009514794A5 JP2008529702A JP2008529702A JP2009514794A5 JP 2009514794 A5 JP2009514794 A5 JP 2009514794A5 JP 2008529702 A JP2008529702 A JP 2008529702A JP 2008529702 A JP2008529702 A JP 2008529702A JP 2009514794 A5 JP2009514794 A5 JP 2009514794A5
Authority
JP
Japan
Prior art keywords
ifn
polypeptides
use according
expressing
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008529702A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514794A (ja
JP5172679B2 (ja
Filing date
Publication date
Priority claimed from GB0518425A external-priority patent/GB0518425D0/en
Application filed filed Critical
Priority claimed from PCT/GB2006/050281 external-priority patent/WO2007029041A2/en
Publication of JP2009514794A publication Critical patent/JP2009514794A/ja
Publication of JP2009514794A5 publication Critical patent/JP2009514794A5/ja
Application granted granted Critical
Publication of JP5172679B2 publication Critical patent/JP5172679B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008529702A 2005-09-09 2006-09-08 呼吸器疾患の治療のためのインターフェロン−λ療法 Expired - Fee Related JP5172679B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0518425.4 2005-09-09
GB0518425A GB0518425D0 (en) 2005-09-09 2005-09-09 Methods
US78329706P 2006-03-17 2006-03-17
US60/783,297 2006-03-17
PCT/GB2006/050281 WO2007029041A2 (en) 2005-09-09 2006-09-08 Interferon lambda therapy for treatment of respiratory diseases

Publications (3)

Publication Number Publication Date
JP2009514794A JP2009514794A (ja) 2009-04-09
JP2009514794A5 true JP2009514794A5 (enExample) 2009-11-05
JP5172679B2 JP5172679B2 (ja) 2013-03-27

Family

ID=37575101

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008529702A Expired - Fee Related JP5172679B2 (ja) 2005-09-09 2006-09-08 呼吸器疾患の治療のためのインターフェロン−λ療法

Country Status (4)

Country Link
EP (1) EP1922081B1 (enExample)
JP (1) JP5172679B2 (enExample)
CA (1) CA2622016A1 (enExample)
WO (1) WO2007029041A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4094475B2 (ja) 2003-04-21 2008-06-04 富士重工業株式会社 多気筒エンジンの燃焼圧データ収集システム
US7871603B2 (en) 2007-05-18 2011-01-18 Synairgen Research Limited Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly
US8282964B2 (en) 2007-10-27 2012-10-09 Medical Diagnostic Laboratories, Llc Ex-vivo treatment of peripheral plasmacytoid dendritic cells with IFN-lambda
US8354125B2 (en) 2007-10-27 2013-01-15 Grant Gallagher Ex-vivo treatment of peripheral blood leukocytes with IFN-λ
WO2010135649A1 (en) * 2009-05-21 2010-11-25 Schering Corporation Genetic markers associated with interferon-alpha response
HRP20161158T1 (hr) 2010-03-12 2016-11-18 Synairgen Research Limited Interferon beta za liječenje bolesti donjeg dišnog sustava izazvane gripom
CN104203982B (zh) 2011-10-28 2018-08-31 特瓦制药澳大利亚私人有限公司 多肽构建体及其用途
WO2021245318A1 (es) * 2020-06-04 2021-12-09 Conicet - Consejo Nacional De Investigaciones Científicas Y Técnicas Método para tratar infecciones del tracto respiratorio producidas por virus
US20220040265A1 (en) 2020-08-07 2022-02-10 Peter G. Carroll Compositions and methods for preventing and/or inhibiting viral infection and spread
EP4553084A3 (en) * 2020-11-04 2025-11-26 Ethris GmbH Use of ifn-lambda mrna for treating viral infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040037809A1 (en) * 2002-06-28 2004-02-26 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of interferon beta
WO2005047331A2 (en) * 2003-11-07 2005-05-26 Immunex Corporation Antibodies that bind interleukin-4 receptor
GB0405634D0 (en) * 2004-03-12 2004-04-21 Univ Southampton Anti-virus therapy for respiratory diseases

Similar Documents

Publication Publication Date Title
Cazzola et al. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease
Kumar et al. Intranasal drug delivery: A non-invasive approach for the better delivery of neurotherapeutics
Guastella et al. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research
TWI343265B (en) Devices for delivering aerosolized drug and ventilator circuits
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
US20110293686A1 (en) Anti-viral compositions and methods for administration
CN114340640A (zh) 用于治疗、改善或预防冠状病毒感染的制造产品和方法
ES2992423T3 (es) Nuevo uso del agonista del receptor de angiotensina II tipo 2
JP2011144201A5 (enExample)
JP2007520506A5 (enExample)
JP2023526547A (ja) 気道粘膜におけるウイルス複製を低下させるための特定の薬物のシステム、方法、及び使用
Mehta et al. Novel and evolving therapies for COVID-19 related pulmonary complications
JP2009514794A5 (enExample)
US20230158259A1 (en) Products of manufacture and methods for treating, ameliorating or preventing microbial infections
CN100542575C (zh) 一种治疗鼻炎的药物及其制备方法
WO2013026270A1 (zh) 右布洛芬左西替利嗪缓释双层片在治疗气道炎症中的用途
CN111467354B (zh) 格列齐特在制备治疗肺纤维化疾病药物中的应用
CN108379329A (zh) 一种抗流感病毒的中药组合物及其制备方法
US20130123364A1 (en) N6-(1-iminoethyl)-l-lysine for regeneration of alveoli in lungs
AU2021254262A1 (en) Methods for treatment of coronavirus infections
KR20230005937A (ko) 바이러스 감염의 치료 또는 예방을 위한 클로파지민 조성물 및 방법
Agarwal et al. An Overview of Formulations for the Treatment of Pulmonary Fibrosis
CN102824638B (zh) 一种含扎鲁司特和他汀类药物的药物组合物
CN103284954A (zh) 惰性纤维素鼻喷剂
Lu et al. Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection